Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
52%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
PBPH
56
HOLDINGS
48%
ALSO IN FTXH
FTXH
51
HOLDINGS
48%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.5% | 7.3% | 7.3% |
|
ABBVIE INC | 7.2% | 7.8% | 7.2% |
|
JOHNSON & JOHNSON | 10.0% | 7.1% | 7.1% |
|
MERCK & CO. INC. | 5.7% | 7.1% | 5.7% |
|
GILEAD SCIENCES INC | 4.0% | 3.7% | 3.7% |
PBPH Overweight Relative to FTXH
|
ELI LILLY & CO | 8.1% |
 |
ASTRAZENECA PLC | 4.7% |
 |
NOVARTIS AG | 4.2% |
|
JOHNSON & JOHNSON | 2.9% |
 |
NOVO NORDISK A/S-B | 2.6% |
|
GSK PLC | 2.0% |
 |
SANOFI-AVENTIS | 1.9% |
 |
CSL LIMITED | 1.3% |
 |
ARGEN-X SE | 1.3% |
|
NATERA INC | 1.2% |
PBPH Underweight Relative to FTXH
|
PFIZER INC | -3.7% |
|
VIATRIS, INC. | -3.4% |
|
BIOGEN IDEC INC | -3.0% |
|
UNITED THERAPEUTICS CORP | -3.0% |
|
ZOETIS INC | -2.9% |
|
INCYTE CORP | -2.7% |
 |
JAZZ PHARMACEUTICALS PLC | -2.2% |
|
EXELIXIS INC | -2.1% |
|
REGENERON PHARMACEUTICALS | -1.8% |
|
HALOZYME THERAPEUTICS INC | -1.6% |